首页 | 本学科首页   官方微博 | 高级检索  
     


Promising Novel Agents for Aggressive B-Cell Lymphoma
Affiliation:1. Department of Pathology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA;2. Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA;1. Department of Rehabilitation, The Second Hospital of Shandong University, Shandong University, Jinan, Shandong 250033, PR China;2. Department of Physical Medicine and Rehabilitation, Zibo Central Hospital, Zibo, Shandong 255036, PR China;3. Department of Obstetrics, Zibo Central Hospital, Zibo, Shandong 255036, PR China;1. Division of Hematology/Oncology, University of California, San Francisco, 505 Parnassus Avenue, San Francisco, CA 94143, USA;2. Division of Hematology/Oncology, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, M1282 Box 1270, San Francisco, CA 94143, USA;1. Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA;2. HIV and Stem Cell Therapeutics, Cancer Therapeutic Evaluation Program (CTEP), National Cancer Institute, Bethesda, MD 20892, USA;1. Division of Pathophysiology, Research Center for Genomic Medicine, Saitama Medical University, 1397-1 Yamane, Hidaka-shi, Saitama 350-1241, Japan;2. Division of Orthodontics, Department of Human Development and Fostering, Meikai University School of Dentistry, 1-1 Keyakidai, Sakado-shi, Saitama 350-0283, Japan;3. Division of Developmental Biology, Research Center for Genomic Medicine, Saitama Medical University, 1397-1 Yamane, Hidaka-shi, Saitama 350-1241, Japan;1. Division of Thoracic Surgery, Department of Surgery, Boston University School of Medicine, Boston, Mass;2. Clinical and Translational Science Institute, Boston University School of Medicine, Boston, Mass;3. General Surgery Training Program, Boston University School of Medicine, Boston, Mass;4. Department of Pathology and Laboratory Medicine, Boston Medical Center, Boston University School of Medicine, Boston, Mass;5. Division of Surgical Research, Department of Surgery, Boston University School of Medicine, Boston, Mass
Abstract:
Keywords:Diffuse large B-cell lymphoma  B-cell receptor  BCL2 inhibitor  EZH2 inhibitor
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号